Due to restrictions following results are derived from synthetic data to demonstrate capability of Computational Healthcare. Please do no derive any inferences from results below.

Rehospitalizations

Numerator 230

Discharged

Denominator 860

Rehospitalization Rate

230 / 860 = 26.7 %

Index = Discharged + Died + Transferred

930 (100%) = 860 (92.5%) + 0 (0.0%) + 0 (0.0%)

Aggregation Policy
Minimum count20
Multiple10
Min hospitals2
Min subset200

Rehospitalization during 50 days since discharge:

Mean ΔT: 27.46 days FQ: 9 days Median: 21 days TQ: 41 days

Rehospitalization during 50 weeks since discharge:

Mean ΔT: 3.48 weeks FQ: 1 weeks Median: 3 weeks TQ: 5 weeks
Sex Distribution
Sex Initial Sub Discharged
Male 56.52 % 56.52 % 44.19 %
Female 39.13 % 39.13 % 53.49 %
Race Distribution
Race Initial Sub Discharged
White 13.04 % 13.04 % 13.95 %
Black 13.04 % 13.04 % 15.12 %
Hispanic 13.04 % 13.04 % 12.79 %
Asian or Pacific Islander 8.7 % 13.04 % 11.63 %
Native American 13.04 % 13.04 % 15.12 %
Other 13.04 % 13.04 % 13.95 %
Race missing, unknown 13.04 % 8.7 % 13.95 %
Payer Distribution
Payer Initial Sub Discharged
Medicare 13.04 % 13.04 % 15.12 %
Medicaid 13.04 % 13.04 % 12.79 %
Private insurance 8.7 % 8.7 % 13.95 %
Self-pay 13.04 % 13.04 % 13.95 %
Other payer 8.7 % 17.39 % 13.95 %
Unknown payer 13.04 % 8.7 % 11.63 %
No charge 13.04 % 13.04 % 15.12 %
Source Distribution
Source Initial Sub Discharged
Another health facility including LTC 17.39 % 13.04 % 18.6 %
Emergency department 17.39 % 17.39 % 18.6 %
Unknown 13.04 % 17.39 % 13.95 %
Court/Law enforcement 17.39 % 8.7 % 16.28 %
Routine, birth, etc 13.04 % 17.39 % 15.12 %
Another hospital 13.04 % 17.39 % 13.95 %
Disposition Distribution
Disposition Initial Sub Discharged
Home Health Care 26.09 % 17.39 % 18.6 %
Died in hospital 0.0 % 13.04 % 0.0 %
Transfer other SNF, ICF, etc. 17.39 % 17.39 % 18.6 %
Routine 52.17 % 39.13 % 60.47 %
Length of Stay Distribution
Discharged
Initial
Subsequent
Visits Mean LOS First quartile Median Third quartile
Discharged 8.43 days 2 days 5 days 11 days
Initial 10.12 days 4 days 7 days 13 days
Sub 7.57 days 3 days 5 days 8 days
Age Distribution
Discharged
Initial
Subsequent
Visits Mean Age First quartile Median Third quartile
Discharged 65.56 year 55 year 67 year 77 year
Initial 68.05 year 59 year 70 year 78 year
Sub 68.2 year 59 year 69 year 80 year
Procedure Distribution
Procedure Code Description Initial Sub Discharged
P3324 Closed [endoscopic] biopsy of bronchus 0.0 % 0.0 % 2.33 %
P3326 Closed [percutaneous] [needle] biopsy of lung 0.0 % 0.0 % 2.33 %
P3893 Venous catheterization, not elsewhere classified 8.7 % 8.7 % 5.81 %
P9925 Injection or infusion of cancer chemotherapeutic substance 21.74 % 8.7 % 12.79 %
P9229 Other radiotherapeutic procedure 100.0 % 17.39 % 100.0 %
P9904 Transfusion of packed cells 17.39 % 21.74 % 12.79 %
P3491 Thoracentesis 0.0 % 0.0 % 2.33 %
DRG Distribution
DRG Code Description Initial Sub Discharged
DG239 DRG V24 : PATHOLOGICAL FRACTURES & MUSCULOSKELETAL & CONN TISS MALIGNANCY 8.7 % 0.0 % 9.3 %
DG300 DRG V24 : ENDOCRINE DISORDERS W CC 0.0 % 0.0 % 4.65 %
DG10 DRG V24 : NERVOUS SYSTEM NEOPLASMS W CC 8.7 % 0.0 % 9.3 %
DG301 DRG V24 : ENDOCRINE DISORDERS W/O CC 0.0 % 0.0 % 16.28 %
DG82 DRG V24 : RESPIRATORY NEOPLASMS 8.7 % 8.7 % 6.98 %
DG409 DRG V24 : RADIOTHERAPY 0.0 % 0.0 % 5.81 %
DG410 DRG V24 : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS 0.0 % 0.0 % 2.33 %
DG403 DRG V24 : LYMPHOMA & NON-ACUTE LEUKEMIA W CC 0.0 % 0.0 % 2.33 %
Diagnosis Distribution
Diagnosis Code Description Initial Primary Sub Primary Discharged Primary Initial All Sub All Discharged All
D1960 Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D1985 Secondary malignant neoplasm of bone and bone marrow 13.04% 0.0% 9.3% 17.39% 13.04% 12.79%
D311 Depressive disorder, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D5990 Urinary tract infection, site not specified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D4019 Unspecified essential hypertension 0.0% 0.0% 0.0% 13.04% 13.04% 18.6%
DV5811 Encounter for antineoplastic chemotherapy 0.0% 0.0% 2.33% 0.0% 0.0% 3.49%
D2724 Other and unspecified hyperlipidemia 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
DV103 Personal history of malignant neoplasm of breast 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D28522 Anemia in neoplastic disease 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
DV1582 Personal history of tobacco use 0.0% 0.0% 0.0% 8.7% 8.7% 8.14%
D3383 Neoplasm related pain (acute) (chronic) 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D27651 Dehydration 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D3051 Tobacco use disorder 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2859 Anemia, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D19889 Secondary malignant neoplasm of other specified sites 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D78701 Nausea with vomiting 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
DV580 Encounter for radiotherapy 0.0% 0.0% 5.81% 0.0% 0.0% 5.81%
D1977 Malignant neoplasm of liver, secondary 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D1970 Secondary malignant neoplasm of lung 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D30000 Anxiety state, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D56400 Constipation, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D73300 Osteoporosis, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D193 Malignant neoplasm of thyroid gland 0.0% 0.0% 20.93% 0.0% 0.0% 23.26%
D2449 Unspecified acquired hypothyroidism 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D496 Chronic airway obstruction, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D1983 Secondary malignant neoplasm of brain and spinal cord 8.7% 0.0% 9.3% 8.7% 8.7% 8.14%
D2720 Pure hypercholesterolemia 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D25000 Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D1629 Malignant neoplasm of bronchus and lung, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D2768 Hypopotassemia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D53081 Esophageal reflux 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2761 Hyposmolality and/or hyponatremia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
External Causes Distribution
External Cause Code Description Initial Sub Discharged
EE9320 Adrenal cortical steroids causing adverse effects in therapeutic use 0.0 % 0.0 % 3.49 %
EE8497 Accidents occurring in residential institution 13.04 % 8.7 % 10.47 %
EE9331 Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 8.7 % 0.0 % 6.98 %
EE8490 Accident in home 0.0 % 8.7 % 4.65 %